The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathwaysHang Li, Lihong Ye, Mian Jiang et al.|Acta Pharmacologica Sinica|2018Cited by 25